Skip to main content Accessibility help
×
Home
  • Print publication year: 2012
  • Online publication date: November 2012

4 - Strengthening health systems

Summary

Executive summary

RethinkHIV seeks answers to the question: “How can additional spending, $2 billion per annum over five years, a total of $10 billion, best be spent across a range of treatment, prevention, research, etc., measures in sub-Saharan Africa (SSA) to respond to HIV/AIDS?” Among the prospective options is an effective bridging between actions focused specifically on HIV/AIDS, and actions that aim to strengthen health systems. The strengthening health systems component considers below these possible solutions:

Universal testing, informing, and counseling can be achieved with a voucher of $5 paid to each of the 400 million adults who accept to learn their HIV status. The cost is substantial at $2 billion, but benefits of knowledge could cut new infections by a quarter million annually, and the B/C ratio would range between a low of 2.5 and a high of 15.

Deployment of community health workers to the rural population at a cost of $2.64 billion could cut maternal deaths by 0.3 million annually and child deaths by millions more, with B/C ratios ranging from about 1.1 to 9.5.

Reducing the opportunistic infection of cryptococcal meningitis (CM) at a cost of $1.5 billion can yield a ratio of benefits to costs between 2.7 and 20.

An Abuja Goals Fund (AGF) can offer a cash on delivery (COD) incentive for meeting-agreed goals of spending 15 percent or more of public revenues on public health, yielding a ratio of benefits to cost between 1.1 and 8.

The analysis of these solutions applies cost-benefit analysis (CBA) to provide guidance for resource allocation at the margin between these and other potential solutions to health deficiencies in SSA. Each of the solutions reviewed offers positive returns of benefits compared to the incremental costs that would be incurred to implement them (see Table 4.1). The analysis considers scenarios in which the value of a year of life is set at $1,000 or $5,000 to include the range of income levels in SSA. The net present value (NPV) of future years of life is assessed using both a 3 percent and a 5 percent discount rate. Once these values for a life-year are adjusted to yield net present values of all the years of life that can be saved by a solution, we calculate the ratio of these two measures of benefits to the costs identified.

Related content

Powered by UNSILO
References
Aids 2031 Costs and Financing Working Group 2009 Synthesis ReportWashington DCResults for Development
Ainsworth, M.World Bank and Operations Evaluation Dept 2005 Committing to Results: Improving the Effectiveness of HIV/AIDS Assistance. An OED Evaluation of the World Bank's Assistance for HIV/AIDS ControlWashington DCWorld Bankwww.worldbank.org/oed/aids/docs/report/hiv%5Fcomplete%5Freport.pdf
Amico, Aran, C.Avila, C. 2010 HIV spending as a share of total health expenditure: an analysis of regional variation in a multi-country studyPLoS One 5
Avila, C. 2009 HIV and AIDS Programs: How they Support Health System StrengtheningWashington DCResults for Development Institute
Avila, C. 2010 Post-Crisis AIDS Financing: Smarter Choices, Integration and EfficiencyGenevaUNAIDS
Baird, S.Chirwa, E.McIntosh, C.Ozler, B. 2009 The Short Term Impacts of a Schooling Conditional Cash Transfer Program on the Sexual Behavior of Young WomenWashington DCWorld Bank
Banerjee, A. V.Duflo, E. 2011 Poor Economics, a Radical Rethinking of the Way to Fight Global PovertyNew YorkPublic Affairs
Barder, O.Birdsall, N. 2006
Belli, P.Anderson, J. R.Barnum, H. N.Dixon, J. A.Tan, J. P. 2001 Economic Analysis of Investment Operations: Analytical Tools and Practical ApplicationsWashington DCWorld Bank, WBI Development Studies
Bicanic, T.Harrison, T. S. 2005 Cryptococcal meningitisBr Med Bull 72 99
Biesma, R.Harmer, B. R.Walsh, A.Spicer, N.Walt, G. 2009 The effects of global health initiatives on country health systems: a review of the evidence from HIV/AIDS controlHealth Policy Plan 24 239
Birdsall, N.Savedoff, W. 2010 Cash on Delivery: A New Approach to Foreign Aid, with an Application to Primary SchoolingBaltimore, MDBrookings Institution Press
Boehme, C. 2011 Feasibility, diagnostic accuracy, and effectiveness of decentralized use of the Xpert MTG/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation studyThe Lancet 377 1495
Bollinger, L. 2011 Prevention of Non-Sexual Transmission of HIVAssessment Paper
Bongaarts, J.Over, M. 2010 Global HIV/AIDS policy in transitionScience 328 1359
Bongaarts, J.Sinding, S. 2009 A response to critics of family planning programsInternational Perspectives on Sexual and Reproductive Health 35 40
Briscombe, B.McGreevey, W. 2010 Costs and Benefits Study of the NHIS/MDG Maternal and Child Health ProjectWashington DCFutures Group
Canning, D. 2006 The economics of HIV/AIDS in low-income countries: the case for preventionJournal of Economic Perspectives 20 121
CHW Technical Task Force 2011 One Million Community Health Workers: Technical Task Force ReportNew YorkThe Earth Institute, Columbia University
Cutler, D 2004 Your Money or Your LifeNew YorkOxford University Press
Cutler, D. M. 2008 Are we finally winning the war on cancer?Journal of Economic Perspectives 22 3
Cutler, D. M.Deaton, A.Lleras-Muney, A. 2006 The determinants of mortalityJournal of Economic Perspectives 20 97
Cutler, D. MMiller, G. 2005 The role of public health improvements in health advancesDemography 42 1
de Lalla, F.Pellizzer, G.Vaglia, A.Manfrin, V.Franzetti, M.Fabris, P.Stecca, C 1995 Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: reliability of relatively high doses administered over a relatively short periodClin Infect Dis 20 263
Department of Health, South Africawww.doh.gov.za/
de Savigny, D.Adam, T. 2009 Systems Thinking for Health Systems StrengtheningGenevaWHO Press
Dodd, P. J.Garnett, G. P.Hallett, T. B 2010 Examining the promise of HIV elimination by “test and treat” in hyperendemic settingsAIDS 24 729
Dromer, F.Bernede-Bauduin, C.Guillemot, D.Lortholary, O.French Cryptococcosis Study Group 2008 Major role for amphotericin B-flucytosine combination in severe cryptococcosisPLoS One 3
Dugger, C. W 2010
Dupas, P 2010 www.nber.org/papers/w14707
Eichler, R.Glassman, A 2008 Health Systems Strengthening Via Performance-Based Aid: Creating Incentives to Perform and to Measure ResultsBaltimore, MDBrookings Institution
Eichler, R. 2009 Performance Incentives for Global Health: Potential and PitfallsBaltimore, MDBrookings Institution Press
England, R 2007 Are we spending too much on HIV?British Medical J 334
Epstein, H 2007 The Invisible Cure: Africa, The West, and the Fight Against AIDSNew YorkFarrar, Strauss and Giroux
Fasawe, O. 2011
Fernald, L. C 2009 10-year effect of Oportunidades, Mexico's conditional cash transfer programme, on child growth, cognition, language, and behaviour: a longitudinal follow-up studyThe Lancet 374 1997
Filmer, D.Hammer, J.Pritchett, L. 2000 Weak links in the chain: a diagnosis of health policy in poor countriesThe World Bank Research Observer 15 199
Filmer, D.Hammer, J.Pritchett, L. 2002 Weak links in the chain II: a prescription for health policy in poor countriesThe World Bank Research Observer 17 47
Filmer, D.Pritchett, L. 1999 The impact of public spending on health: does money matter?Social Science and Medicine 49 1309
Fiszbein, A. 2009 Conditional Cash Transfers: Reducing Present and Future PovertyWashington DCWorld Bank
Fox-Rushby, J. A.Hanson, K 2001 Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysisHealth Policy and Planning 16 326
Garnett, G. P.Baggaley, R. F. 2009 Treating our way out of the HIV pandemic: could we, would we, should we?Lancet 373 9
Glassman, A.Savedoff, W. 2011 The health systems funding platform: resolving tensions between the aid and development effectiveness agendasWashington DCCenter for Global Development
Global Fund Observer 2011
Gottret, P.Waters, H.Schieber, G. 2008 Good Practices in Health Financing: Lessons From Reforms in Low- and Middle-Income CountriesWashington DCWorld Bank
Gottret, P. 2009 Protecting Pro-Poor Health Services During Financing Crises, Lessons From ExperienceWashington DCWorld Bank
Graham, C 2009 Happiness Around the world: The Paradox of Happy Peasants and Miserable MillionairesOxford University Press
Granich, R. M 2008 Universal voluntary HIV testing with immediate anti-retroviral therapy as a strategy for elimination of HIV transmission: a mathematical modelThe Lancet online
Guthrie, T. 2010 The Long Run Costs and Financing of HIV/AIDS in South AfricaWashington DCResults for Development Institute
Hecht, R. 2010 Costs and Choices: Financing the Long-Term Fight against AIDSWashington DCResults for Development Institute
Hecht, R. 2010 Critical choices in financing the response to the global HIV/AIDS pandemicHealth Affairs 28 1
Herbst, C. H 2009
IHP+ the International Health Partnership 2008 Update
IHP+ the International Health Partnership 2008
IHP+ the International Health Partnership 2009
IHP+ the International Health Partnership 2009
IHP+ the International Health Partnership 2009 www.internationalhealthpartnership.net/ihp_plus_documents.html
IHP+ the International Health Partnership 2009
IHP+ the International Health Partnershipwww.internationalhealthpartnership.net/ihp_plus_about_objectives.html
IHP+ Advisory Group 2011 IHP+ Results: Strengthening Accountability to Achieve the Health MDGs. Annual Performance Report 2010LondonResponsible Action UK
Jamison, D. T 2010 Disease controlLomborg, B.Smart Solutions To Climate Change: Comparing Costs and BenefitsCambridge University Press
Jamison, D. T. 2006 Disease Control Priorities in Developing CountriesWashington DCWorld Bank and Oxford University Press
Jamison, D. T. 2006 Priorities in HealthWashington DCWorld Bank
Jarvis, J. N.Lawn, S. D.Vogt, M.Bangani, N.Wood, R.Harrison, T. S 2009 Screening for cryptococcal antigenemia in patients accessing an anti-retroviral treatment program in South AfricaClin Infect Dis 48 856
Joshi, S 2011 How effective are family-planning programs at improving the lives of women?Some perspectives from a vast literatureWashington DCGeorgetown University
Karlan, D.Appel, J. 2011 More than Good Intentions: How a New Economics is Helping to Solve Global PovertyNew YorkDutton
Kenny, C 2011 Getting Better: Why Global Development Is Succeeding – and How We Can Improve the World Even MoreNew YorkBasic Books
Kranzer, K. 2011 Improving tuberculosis diagnostics and treatmentThe Lancet 377 1467
Levy, S 2006 Progress against Poverty: Sustaining Mexico's Progresa-Oportunidades ProgramWashington DCBrookings Institution Press
Lomborg, B 2004 Global Crises, Global SolutionsCambridge University Press
Lomborg, B 2006 How to Spend $50 Billion to Make the World a Better PlaceCambridge University Press
Lomborg, B 2007 Solutions for the World's Biggest Problems: Costs and BenefitsCambridge University Press
Lu, C.Schneider, M.Gubbins, P.Leach-Kemon, K.Jamison, D.Murray, C. J. L 2010 Public financing of health in developing countries: a cross-national systematic analysisLancet 375 1375
Lule, E. LSeifman, R. M.David, A. C. 2009 The Changing HIV/AIDS Landscape: Selected Papers for the World Bank's Agenda for Action in Africa, 2007–2011Washington DCWorld Bank
Mathers, C. 2009 Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major RisksGenevaWHO
McCoy, D.Brikci, N. 2010 Taskforce on innovative international financing for health systems: what next?Bulletin of the World Health Organization 88 478
McGreevey, W 2009
McGreevey, W.MacKellar, L. 2007 Economic rate of return report: economic analysis of the Lesotho health projectMimeoMarch
McNeil, D. G 2010
McNeil, D. G 2010
McNeil, D. G. 2011
Medlin, C.de Walque, D. 2008 Potential Application of Conditional Cash Transfers for Prevention of Sexually Transmitted Infections and HIV in Sub-Saharan AfricaWashington DCWorld Bank Policy Research Working Paper No.
Meya, D. B.Manabe, Y. C.Castelnuovo, B.Cook, B. A.Elbireer, A. M.Kambugu, A.Kamya, M. R.Bohjanen, P. R.Boulware, D. R 2010 Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settingsClin Infect Dis 51 448
Micol, R.Tajahmady, A.Lortholary, O.Balkan, S.Quillet, C.Dousset, J. P.Chanroeun, H.Madec, Y.Fontanet, A.Yazdanpanah, Y 2010 Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in CambodiaPLoS One 5
Milanovic, B 2011 The Haves and the Have-Nots, a Brief and Idiosyncratic History of Global InequalityNew YorkBasic Books
Mills, A 2009 Constraints to Scaling Up and Costs. Working Group ReportTaskforce on innovative international financing for health systems
Mills, A.Shillcutt, S. 2007 Communicable diseasesLomborg, B. 2006 How to Spend $50 Billion to Make the World a Better PlaceCambridge University Press19
Narayan, D.Chambers, R.Kaul Shah, M.Petesch, P 2000 Voices of the Poor, Crying Out for ChangeWashington DCOxford University Press for World Bank
Nordhaus, W. D. 2003 The health of nations: the contribution of improved health to living standardsMurphy, K. M.Topel, R. H.Measuring the Gains from Medical Research: An Economic ApproachUniversity of Chicago Press
Nordhaus, W. D 2008 The question of global warming: an exchangeThe New York 55
Nossiter, A 2011
Ooms, G. 2008 The “diagonal” approach to Global Fund financing: a cure for the broader malaise of health systems?Globalization and Health 4 6
Over, M 2008 Prevention Failure: The Ballooning Entitlement Burden of U.S. Global AIDS Treatment Spending and What to Do about ItWashington DCCenter for Global Development
Over, M 2010 Using Incentives to Prevent HIV InfectionsWashington DCCenter for Global Development
Park, B. J 2009 Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDSAIDS 2009 23 525
Perfect, J. R.Dismukes, W. E.Dromer, F.Goldman, D. L.Graybill, J. R.Hamill, R. J.Harrison, T. S.Larsen, R. A.Lortholary, O.Nguyen, M. H.Pappas, P. G.Powderly, W. G.Singh, N.Sobel, J. D.Sorrell, T. C 2010 Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of AmericaClin Infect Dis 50 291
Piot, P.Kazatchkine, M.Dybul, M.Lob-Levyt, J. 2009
Post, S.McGreevey, W. 2005 Additionality: Dimensions, Issues and Indicators. Measuring the Systems Effect of the Global Fund with a Focus on Additionality, Partnerships, and SustainabilityGenevaThe Global Fund
Punchak, M 2011 Cost-effectiveness of cryptococcal antigen screening of at-risk HIV/AIDS patients in South Africa in order to save lives associated with human cryptococcosis. DraftLondonLSHTM
Raja, S.Bates, J. 2009 Strengthening health systems: the role of supply chains in addressing the HIV epidemicLule, E. L.Seifman, R. M.David, A. C. 2009 The Changing HIV/AIDS Landscape: Selected Papers for the World Bank's Agenda for Action in Africa, 2007–2011Washington DCWorld Bank411
Robberstad, B.Evjen-Olsen, B. 2010 Preventing mother to child transmission of HIV with highly active antiretroviral treatment in Tanzania – a prospective cost-effectiveness studyJaids – Journal of Acquired Immune Deficiency Syndromes 55 397
Roberts, M. J.Hsiao, W.Berman, P.Reich, M. R 2004 Getting Health Reform Right: A Guide to Improving Performance and EquityNew YorkOxford University Press
Savedoff, W 2010 Basic economics of result-based financing in healthBath, MaineSocial Insight
Scharfstein, J. A.Paltiel, A. D.Freedberg, K. A 1997 The cost-effectiveness of fluconazole prophylaxis against primary systemic fungal infections in AIDS patientsMed Decis Making 17 373
Schwartländer, B. 2001 AIDS. Resource needs for HIV/AIDSScience 292 2434
Schwartländer, B. 2011
Serneels, P. 2005
Shillcutt, S. DWalker, D. G.Goodman, Mills, A. J. 2009 Cost-effectiveness in low- and middle-income countries: a review of the debates surrounding decision rulesPharmacoeconomics 27 903
Sloan, D. J.Dedicoat, M. J.Lalloo, D. G 2009 Treatment of cryptococcal meningitis in resource limited settingsCurr Opin Infect Dis 22 455
Tandon, A 2009 Development assistance for health: some recent trends and implicationsWashington DCWorld Bank
Task Force on Innovative International Financing for Health Systems 2009 More Money for Health, and More Health for the MoneyGenevaWHO
The Economist 2011 89
The New York Times 2011
Thornton, R. 2005 The Demand for and Impact of Learning HIV Status: Evidence from a Field ExperimentSouthern African Regional Poverty Network
United Nations 2011 The Millennium Development Goals ReportNew YorkUnited Nations
Viscusi, W. K 1993 The value of risks to life and healthJournal of Economic Literature 31 1912
Viscusi, W. K.Aldy, J. E. 2003 The value of a statistical life: a critical review of market estimates throughout the worldThe Journal of Risk and Uncertainty 27 5
Warner, A 2010 Cost-Benefit Analysis in World Bank ProjectsWashington DCIndependent Evaluation Group, World Bank
World Health Organization 2007 Everybody's Business: Strengthening Health Systems to Improve Health Outcomes. WHO's Framework for ActionGenevaWorld Health Organization